P400 BUDESONIDE ORAL SUSPENSION TREATMENT IMPROVES DYSPHAGIA SYMPTOMS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

I. Hirano,M. Collins, D. Katzka,V. Mukkada, G. Falk, D. Johnston,D. Soteres, J. Williams, N. Desai, L. Lan, R. Morey,E. Dellon

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY（2019）

Cited 1|Views7

No score

Abstract

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease. Symptoms are central to the diagnosis and therapeutic outcomes of EoE. The Dysphagia Symptom Questionnaire (DSQ) is the only daily instrument validated for the symptoms of EoE. This study examined the efficacy of budesonide oral suspension (BOS; SHP621) on dysphagia in patients with EoE.

Translated text

Key words

eosinophilic esophagitis,dysphagia symptoms,oral suspension treatment

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined